Abstract
Our current understanding of human physiology and activities is largely derived from sparse and discrete individual clinical measurements. To achieve precise, proactive, and effective health management of an individual, longitudinal, and dense tracking of personal physiomes and activities is required, which is only feasible by utilizing wearable biosensors. As a pilot study, we implemented a cloud computing infrastructure to integrate wearable sensors, mobile computing, digital signal processing, and machine learning to improve early detection of seizure onsets in children. We recruited 99 children diagnosed with epilepsy and longitudinally tracked them at single-second resolution using a wearable wristband, and prospectively acquired more than one billion data points. This unique dataset offered us an opportunity to quantify physiological dynamics (e.g., heart rate, stress response) across age groups and to identify physiological irregularities upon epilepsy onset. The high-dimensional personal physiome and activity profiles displayed a clustering pattern anchored by patient age groups. These signatory patterns included strong age and sex-specific effects on varying circadian rhythms and stress responses across major childhood developmental stages. For each patient, we further compared the physiological and activity profiles associated with seizure onsets with the personal baseline and developed a machine learning framework to accurately capture these onset moments. The performance of this framework was further replicated in another independent patient cohort. We next referenced our predictions with the electroencephalogram (EEG) signals on selected patients and demonstrated that our approach could detect subtle seizures not recognized by humans and could detect seizures prior to clinical onset. Our work demonstrated the feasibility of a real-time mobile infrastructure in a clinical setting, which has the potential to be valuable in caring for epileptic patients. Extension of such a system has the potential to be leveraged as a health management device or longitudinal phenotyping tool in clinical cohort studies.
Author Summary Epilepsy is the most common childhood neurological condition, affecting 0.5-1% of children worldwide. Affected individuals often have unpredictable seizure events, which, if not timely monitored or treated, can have debilitating or life-threatening consequences. We have developed an early alert system, which is based on wearable devices (e.g., wristband) connected to an adjacent cell phone via Bluetooth. The wearable devices have multiple sensors to collect physiological measurements including heart rate, body movement, and skin responses. These real-time measurements are transmitted via the cell phone to a remote cloud-based computing infrastructure and are compared to the individual’s baseline data. If an abnormal event such as seizure is detected, a message is then pushed to alert the caregiver. In a pilot study tracking 99 epileptic children, we demonstrated that our system was able to detect the onset of seizure events at a high accuracy, often before being noticed by caregivers. Our work demonstrated the feasibility of a real-time mobile infrastructure in a clinical setting, which is valuable in caring for epileptic patients. Extension of such a system has the potential to be leveraged as a health management device or precision phenotyping tool in clinical studies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants from Fundamental Research Funds for the Central Universities (Q.S., 2019XZZX003-16), and National Natural Science Foundation of China (P.J., 81671287). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study described in this paper was approved by the Ethical Committee of the Zhejiang University Children Hospital (ZJUCH) (IRB #2020-IRB-011). The study was performed in accordance with the World Medical Association (WMA) Declaration of Helsinki. Each participating family has signed a written informed consent, agreeing the use of data for scientific research.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Zhaolei.Zhang{at}utoronto.ca (ZZ); shuqiang{at}zju.edu.cn (QS); mpsnyder{at}sensomics.com (MS); lijj{at}sensomics.com (JL)
Data Availability
All data produced in the present study are available upon reasonable request to the authors.